Bernadette Melnyk

dean, ASU College of Nursing & Health Innovation

Bernadette Melnyk is Dean and Distinguished Foundation Professor in Nursing at Arizona State University College of Nursing & Health Innovation. Dr. Melnyk is an internationally recognized expert in theory-based intervention research and evidence-based practice as well as in child and adolescent mental health. She has worked with numerous healthcare systems throughout the nation and globe to advance and sustain evidence-based practice.

Dr. Melnyk’s record of extramural research and educational funding, including grants from the National Institutes of Health (NIH), the Agency for Healthcare Research & Quality, and HRSA totals more than $11 million. Through a series of nine randomized controlled trials, she has supported the efficacy of her COPE intervention program in improving the outcomes of critically ill/hospitalized children and premature infants and parents, which has been adopted by hospitals and insurers throughout the U.S. Her current NIH-funded RO1 grant is a randomized controlled trial testing the efficacy of her COPE/Healthy Lifestyles TEEN program to prevent overweight/obesity and depression in 800 culturally diverse teenagers in Phoenix, Arizona. Dr. Melnyk’s record of scholarship includes over 150 publications, two books, and numerous distinguished awards for her contributions to improving children’s health, nursing and healthcare.

Bernadette Melnyk is Dean and Distinguished Foundation Professor in Nursing at Arizona State University College of Nursing & Health Innovation. Dr. Melnyk is an internationally recognized expert in theory-based intervention research and evidence-based practice as well as in child and adolescent mental health. She has worked with numerous healthcare systems throughout the nation and globe to advance and sustain evidence-based practice.

Dr. Melnyk’s record of extramural research and educational funding, including grants from the National Institutes of Health (NIH), the Agency for Healthcare Research & Quality, and HRSA totals more than $11 million. Through a series of nine randomized controlled trials, she has supported the efficacy of her COPE intervention program in improving the outcomes of critically ill/hospitalized children and premature infants and parents, which has been adopted by hospitals and insurers throughout the U.S. Her current NIH-funded RO1 grant is a randomized controlled trial testing the efficacy of her COPE/Healthy Lifestyles TEEN program to prevent overweight/obesity and depression in 800 culturally diverse teenagers in Phoenix, Arizona. Dr. Melnyk’s record of scholarship includes over 150 publications, two books, and numerous distinguished awards for her contributions to improving children’s health, nursing and healthcare.